GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (LSE:ONT) » Definitions » Retained Earnings

Oxford Nanopore Technologies (LSE:ONT) Retained Earnings : £-257.7 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Oxford Nanopore Technologies's retained earnings for the quarter that ended in Dec. 2023 was £-257.7 Mil.

Oxford Nanopore Technologies's quarterly retained earnings declined from Dec. 2022 (£-106.0 Mil) to Jun. 2023 (£-177.3 Mil) and declined from Jun. 2023 (£-177.3 Mil) to Dec. 2023 (£-257.7 Mil).

Oxford Nanopore Technologies's annual retained earnings declined from Dec. 2021 (£-15.9 Mil) to Dec. 2022 (£-106.0 Mil) and declined from Dec. 2022 (£-106.0 Mil) to Dec. 2023 (£-257.7 Mil).


Oxford Nanopore Technologies Retained Earnings Historical Data

The historical data trend for Oxford Nanopore Technologies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Retained Earnings Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial -397.78 -459.02 -15.90 -105.99 -257.71

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.90 -46.08 -105.99 -177.33 -257.71

Oxford Nanopore Technologies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Oxford Nanopore Technologies  (LSE:ONT) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Oxford Nanopore Technologies (LSE:ONT) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (LSE:ONT) Headlines

No Headlines